TipRanks
Go Ultimate55% OFF

GenSight Biologics SA (G49N) Balance Sheet

GenSight Biologics SA Balance Sheet

GenSight Biologics SA's total assets for Q2 2026 were $6.46M, a decrease of 21.78% from the previous quarter. DE:G49N total liabilities were $40.08M for the fiscal quarter, a 20.72% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 8.26M$ 10.76M$ 9.13M$ 25.94M$ 56.65M
$ 33.20M$ 37.68M$ 39.83M$ 41.22M$ 40.66M
$ -24.94M$ -26.92M$ -30.67M$ -15.28M$ 15.99M

Currency in EUR

GenSight Biologics SA Debt to Assets

025M50M75M0 %200 %400 %600 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets